SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-236340
Filing Date
2020-08-31
Accepted
2020-08-31 17:02:57
Documents
17
Period of Report
2020-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d90221d8k.htm   iXBRL 8-K 30702
2 EX-1.1 d90221dex11.htm EX-1.1 151016
3 EX-5.1 d90221dex51.htm EX-5.1 9446
7 GRAPHIC g90221g09n10.jpg GRAPHIC 904
8 GRAPHIC g90221g13o97.jpg GRAPHIC 883
9 GRAPHIC g90221g69o51.jpg GRAPHIC 5167
  Complete submission text file 0001193125-20-236340.txt   370692

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bstc-20200831.xsd EX-101.SCH 3070
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20200831_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20200831_pre.xml EX-101.PRE 11408
10 EXTRACTED XBRL INSTANCE DOCUMENT d90221d8k_htm.xml XML 3421
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19879 | Film No.: 201152233
SIC: 2834 Pharmaceutical Preparations